Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 8/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20691951 | 0.91 | SLC29A1 (0.37) | SLC29A1 | |
| SCHEMBL20692234 | 0.89 | CNR2 (0.32) | SLC29A1CNR2 | |
| SCHEMBL24680745 | 0.87 | SLC29A1 (0.32) | SLC29A1 | |
| SCHEMBL20691367 | 0.77 | SLC29A1 (0.51) | SLC29A1 | |
| SCHEMBL25688810 | 0.76 | SLC29A1 (0.45) | SLC29A1 | |
| SCHEMBL22349184 | 0.75 | SLC29A1 (0.47) | SLC29A1 | |
| SCHEMBL20692028 | 0.72 | SLC29A1 (0.47) | SLC29A1 | |
| SCHEMBL25688811 | 0.71 | SLC29A1 (0.36) | SLC29A1 | |
| SCHEMBL24680579 | 0.71 | — | — | |
| SCHEMBL24322061 | 0.70 | POLA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3676279-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2021-12-01 | — | — | EP | disclosed |